170 related articles for article (PubMed ID: 3463816)
1. Effects of antimuscarinic agents and prostaglandin E2 on the gastric mucosal lesions induced by necrotizing agents and water-immersion stress in rats.
Kitagawa H; Hayashi T; Takeda F; Kinekawa F; Kohei H
Jpn J Pharmacol; 1986 Jul; 41(3):409-14. PubMed ID: 3463816
[TBL] [Abstract][Full Text] [Related]
2. Gastric cytoprotection by pirenzepine in rats: evaluating method for cytoprotective activity by antisecretory agents.
Takeda F; Kitagawa H; Kohei H
Jpn J Pharmacol; 1985 Aug; 38(4):337-46. PubMed ID: 3865005
[TBL] [Abstract][Full Text] [Related]
3. Effect of prostaglandin E2, cimetidine, and atropine on ethanol-induced gastric mucosal damage in the rat.
Puurunen J
Scand J Gastroenterol; 1980; 15(4):485-8. PubMed ID: 7433913
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the gastric antisecretory and antiulcer potencies of telenzepine, pirenzepine, ranitidine and cimetidine in the rat.
Riedel R; Bohnenkamp W; Eltze M; Heintze K; Prinz W; Kromer W
Digestion; 1988; 40(1):25-32. PubMed ID: 3234616
[TBL] [Abstract][Full Text] [Related]
5. [Anti-ulcerogenic and cytoprotective effects of trimoprostil (Ro 21-6937), a trimethylprostaglandin E2 derivative].
Ohno T; Yamaguchi Y; Yajima T; Nakamura K
Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):131-47. PubMed ID: 6607197
[TBL] [Abstract][Full Text] [Related]
6. Effects of atropine and pirenzepine on healing of gastric ulcer induced by mucosal excision in rats.
Sano M; Kitagawa H; Fujiwara M
Clin Ther; 1985; 7(3):380-9. PubMed ID: 3838920
[TBL] [Abstract][Full Text] [Related]
7. Studies on the mechanism for the gastric mucosal protection by famotidine in rats.
Miyata K; Kamato T; Nishida A; Honda K
Jpn J Pharmacol; 1991 Feb; 55(2):211-22. PubMed ID: 2067140
[TBL] [Abstract][Full Text] [Related]
8. Effects of KW-5805, a new antiulcer agent, on experimental gastric and duodenal ulcers, gastric mucosal lesions by necrotizing agents and gastric acid secretion.
Kosaka N; Tanaka H; Tomaru A; Ishii A; Shuto K
Jpn J Pharmacol; 1994 Aug; 65(4):305-12. PubMed ID: 7990267
[TBL] [Abstract][Full Text] [Related]
9. Effects of cimetidine, atropine and prostaglandin E2 on rat mucosal erosions produced by intragastric distension.
Marti-Bonmati E; Aliño SF; Lloris JM; Esplugues J
Eur J Pharmacol; 1980 Nov; 68(1):49-53. PubMed ID: 7449834
[TBL] [Abstract][Full Text] [Related]
10. Effect of pirenzepine and PGE2 on taurocholic acid-induced gastric lesions.
Varin L; Giachetti A; Brambilla A
Pharmacol Res Commun; 1986 Aug; 18(8):707-15. PubMed ID: 3464029
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the gastric cytoprotective properties of atropine, ranitidine and PGE2 in rats.
Del Soldato P; Foschi D; Varin L; Daniotti S
Eur J Pharmacol; 1984 Oct; 106(1):53-8. PubMed ID: 6099271
[TBL] [Abstract][Full Text] [Related]
12. Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric mucosal lesions induced by necrotizing agents and gastric mucosal defensive factors in rats.
Onoda Y; Takido M; Magaribuchi T; Tamaki H
Jpn J Pharmacol; 1990 Apr; 52(4):631-8. PubMed ID: 2342230
[TBL] [Abstract][Full Text] [Related]
13. Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in the rat.
Yamasaki K; Kanbe T; Chijiwa T; Ishiyama H; Morita S
Eur J Pharmacol; 1987 Oct; 142(1):23-9. PubMed ID: 3480223
[TBL] [Abstract][Full Text] [Related]
14. Effects of antisecretory drugs on mucosal erosions induced by intragastric distension in rats: a comparative study.
Martí-Cabrera M; Esplugues JV; Martí-Bonmati L; Sarria B; Vento A; Martí-Bonmati E; Gil L; Esplugues J
Methods Find Exp Clin Pharmacol; 1988 Jan; 10(1):13-6. PubMed ID: 3162756
[TBL] [Abstract][Full Text] [Related]
15. Gastric motility is an important factor in the pathogenesis of indomethacin-induced gastric mucosal lesions in rats.
Ueki S; Takeuchi K; Okabe S
Dig Dis Sci; 1988 Feb; 33(2):209-16. PubMed ID: 3338368
[TBL] [Abstract][Full Text] [Related]
16. Effects of the new anti-ulcer agent KB-5492 on experimental gastric mucosal lesions and gastric mucosal defensive factors, as compared to those of teprenone and cimetidine.
Morimoto Y; Shimohara K; Oshima S; Sukamoto T
Jpn J Pharmacol; 1991 Dec; 57(4):495-505. PubMed ID: 1803065
[TBL] [Abstract][Full Text] [Related]
17. Gastric mucosa protection and prostaglandin E2 generation in rats by colloidal bismuth subcitrate (DE-NOL).
Hall DW; van den Hoven WE
Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):308-19. PubMed ID: 3473983
[TBL] [Abstract][Full Text] [Related]
18. Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric mucosal damage induced by various necrotizing agents in rats.
Ueda F; Aratani S; Mimura K; Kimura K; Nomura A; Enomoto H
Arzneimittelforschung; 1984; 34(4):478-84. PubMed ID: 6588974
[TBL] [Abstract][Full Text] [Related]
19. Gastric acid secretion and lesion formation in rats under water-immersion stress.
Hayase M; Takeuchi K
Dig Dis Sci; 1986 Feb; 31(2):166-71. PubMed ID: 3943444
[TBL] [Abstract][Full Text] [Related]
20. Further evidences on gastric cytoprotection exerted by pirenzepine.
Varin L; Del Soldato P; Foschi D; De Rosa M
Pharmacol Res Commun; 1984 Jul; 16(7):653-65. PubMed ID: 6591215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
